Respir-WAL SRL
Respir-WAL reported total assets of 296,680 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 May 2026).
The score of Respir-WAL shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +881 % Total assets +408 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Respir-WAL's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 134,458 € | ||||
| Equity | 266,409 € | ||||
| Cash | 144,928 € | ||||
| EBITDA | 188,212 € | ||||
| Total assets | 296,680 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 May 2026
- Year ended 31 Dec 2024filed on 30 Aug 2025
- Year ended 31 Dec 2023filed on 18 Aug 2024
- Year ended 31 Dec 2022filed on 21 Sep 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
Respir-WAL's financial analysis
- Solvency89.8%sector median: 65.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Respir-WAL
Respir-WAL's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0757.766.572
- VAT number
- BE0757766572
- Peppol
- Registered · 0208:0757766572 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 03 Nov 2020
- Registered office
- 7330 Saint-Ghislain
- Latest accounts
- 2025 · filed on 30 May 2026
- Activity
- Medical specialists activities (NACE 86220)
Respir-WAL (SRL) has been based in Saint-Ghislain since 2020, active in: medical specialists activities. For 2025, it reports a net profit of 134,458 € and equity of 266,409 €; its revenue is not published. Its solvency stands at 89.8%, above the median of its sector (65.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Respir-WAL
Companies in the same business, of comparable size and area, outside its group.
- Doyen Benoit Cardiologie Medical specialists activities Namur · balance sheet 296,642 €
- Bel Austra Med Medical specialists activities Namur · balance sheet 297,043 €
- Dokter Liesbet De Wachter Medical specialists activities Leuven · balance sheet 296,602 €
- R-G Medical Medical specialists activities Liège · balance sheet 296,779 €
- DR.P. Steyaert – Medische Expertisen Medical specialists activities Beveren-Kruibeke-Zwijndrecht · balance sheet 296,208 €
- Dopamine Medical specialists activities Braine-le-Château · balance sheet 297,324 €
- Isanesthesia Medical specialists activities Villers-la-Ville · balance sheet 297,347 €
- J-Mochi Medical specialists activities Antwerp · balance sheet 297,360 €
Frequently asked questions about Respir-WAL
What is the revenue of Respir-WAL?
Respir-WAL files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Respir-WAL?
In Belgium, the VAT number is the company number prefixed with BE: BE0757766572 for Respir-WAL, if the company is VAT-registered. Its company number (CBE) is 0757.766.572.
Where is the registered office of Respir-WAL?
According to the CBE register, the registered office of Respir-WAL is in 7330 Saint-Ghislain.
What is the equity of Respir-WAL?
At the close of the 2025 financial year, the equity of Respir-WAL amounts to 266,409 €, a solvency of 89.8% of total assets.
Who manages Respir-WAL?
The register lists 1 active mandates at Respir-WAL. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Respir-WAL
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →